Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Pivotal Study of the Silk Vista Baby Flow Diverters in the Treatment of Unruptured Intracranial Aneurysms (PIONEER)

NCT: NCT07225075 · RECRUITING

NCT IDNCT07225075
StatusRECRUITING
Start Date2026-02-04
Completion2031-02
SponsorBalt USA (INDUSTRY)
First posted
Last updated

Brief Summary

The PIONEER Study is a pivotal, multi-center, prospective, single-arm study designed to evaluate the safety and efficacy of the Silk Vista Baby (SVB) Flow Diverter for the treatment of unruptured aneurysms.

Frequently Asked Questions

What is Pivotal Study of the Silk Vista Baby Flow Diverters in the Treatment of Unruptured Intracranial Aneurysms (PIONEER)?

Pivotal Study of the Silk Vista Baby Flow Diverters in the Treatment of Unruptured Intracranial Aneurysms (PIONEER) is a clinical trial registered under NCT07225075. Current status: RECRUITING.

What is the status of NCT07225075?

The current status of NCT07225075 (Pivotal Study of the Silk Vista Baby Flow Diverters in the Treatment of Unruptured Intracranial Aneurysms (PIONEER)) is: RECRUITING.

When did Pivotal Study of the Silk Vista Baby Flow Diverters in the Treatment of Unruptured Intracranial Aneurysms (PIONEER) start?

Pivotal Study of the Silk Vista Baby Flow Diverters in the Treatment of Unruptured Intracranial Aneurysms (PIONEER) started on 2026-02-04.

Related Devices

K182337HYBRID GuidewireBalt USA, LLC K182918Ballast 088 Long SheathBalt USA, LLC K183045Eclipse 2LBalt USA, LLC K200030Optima Coil SystemBalt USA, LLC K202366MAGIC Infusion CatheterBalt USA, LLC

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑